Sees FY12 revenue $2.81B-$2.86B, consensus $2.61B.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on BRKR:
- Bruker sees 2023 organic revenue growth mid-to-high single digit
- Bruker sees Q4 revenue up low single digits year-over-year
- Bruker acquires ACQUIFER Imaging GmbH, terms not stated
- Bruker, Biognosys form partnership for advanced proteomics CRO services
- Bruker announces ownership investment in Biognosys, terms undisclosed